Target intelligence / Profile preview

Poly(ADP-ribose) polymerase 10 (PARP10)

Target
PARP10
Molecular classification
Enzyme, Mono-ADP-ribosyltransferase, Transferase
01

Overview

Poly(ADP-ribose) polymerase 10 (PARP10) is an enzyme encoded by the PARP10 gene and is part of the PARP family, which is involved in transferring ADP-ribose units from NAD+ to target proteins (mono-ADP-ribosylation). PARP10 is classified as a mono-ADP-ribosyltransferase (mono-ART) and plays a role in the DNA damage response by interacting with proliferating cell nuclear antigen (PCNA) to facilitate translesion DNA synthesis and maintain genomic stability. Loss of PARP10 results in increased genomic instability and hypersensitivity to DNA-damaging agents, while overexpression can either promote apoptosis or cell proliferation depending on cell context. PARP10 suppresses NF-κB signaling and can inhibit the replication of certain single-stranded RNA viruses. It is under investigation as a therapeutic target in cancer and virus-associated diseases, and its activity modulates key cellular processes such as the cell cycle, apoptosis, and DNA repair. Structural studies have characterized its interactions with various inhibitors, providing tools for therapeutic research.

Other names
ARTD10Poly [ADP-ribose] polymerase 10
02

Mechanism of action

Inhibition of ADP-ribosyltransferase activity, leading to compromised DNA repair and increased sensitivity to DNA-damaging agents

03

Biological functions

DNA damage responseDNA repairRegulation of cell cycleCell proliferationInhibition of NF-κB signalingModulation of apoptosisSuppression of viral replication
04

Disease associations

CancerViral infectionGenomic instability
05

Safety considerations

Genomic instability with inhibition or loss, potentially leading to increased cancer risk in non-cancerous tissuesUnintended effects on cell proliferation and apoptosis, cell-type dependent
06

Interacting drugs

3-aminobenzamide (experimental inhibitor)

2 more in the full profile.

07

Biomarkers

PARP10 expression levels for sensitivity to DNA-damaging agentsGenomic instability markers (such as γH2AX) in the context of PARP10 deficiency

Beyond the preview

Go deeper on Poly(ADP-ribose) polymerase 10 (PARP10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poly(ADP-ribose) polymerase 10 (PARP10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call